Filing Details
- Accession Number:
- 0000711377-11-000035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-10-03 17:50:24
- Reporting Period:
- 2011-09-29
- Filing Date:
- 2011-10-03
- Accepted Time:
- 2011-10-03 17:50:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1517426 | J. Steven Quinlan | 620 Lesher Place Lansing MI 48912 | Vice President & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-09-29 | 147 | $34.38 | 647 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Option (Right to Buy) | Acquisiton | 2011-09-29 | 5,000 | $0.00 | 5,000 | $34.61 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,000 | 2016-09-29 | No | 4 | A | Direct |
Footnotes
- Shares acquired are held in the Neogen Corporation 401(k) Plan
- The options were granted September 29, 2011 and vest 20% yearly through September 29, 2016
Billionaire Hedge Funds
